Despite the rejuvenated “risk-on” tone in the market at the moment, today’s article notes that traders are pricing in a lot of risk at one particular point in time in […]
read more
4 Biotech Stocks Worthy Of Close Attention
When it comes to biotech’s performance over the last several weeks, the author of today’s article notes that “Part of the sector’s rise is undoubtedly attributed to the work toward […]
read moreThe Massive – And Mysterious – Rally Of The World’s Best-Performing Stock
What’s clear is that, having surged 2,819% in the past 12 months (and 351% so far this year in the face of a market meltdown), this stock is the best-performing […]
read moreA Better Way To Play The Earnings Game?
Given the ability of earnings reports to catapult stock prices higher in a short period of time, the authors of today’s article state “It’s no wonder why options traders tend […]
read moreRemdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
There is currently only one drug that has demonstrated the potential to be a safe and effective treatment for COVID-19 in clinical trials: Gilead Sciences’ remdesivir. Today’s article, however, highlights […]
read more2 “Compelling” Biotech Stocks That Just Won The Ultimate Prize (FDA Approval)
FDA approval is the ultimate prize in the biotech industry – and one of the few major catalysts for biotech stocks. As a result, having just received FDA approval for […]
read more3 Penny Stocks To Monitor Amid The Market Mayhem
While markets stabilized somewhat in recent days, today’s article acknowledges that “We will see significant volatility in the coming weeks as concerns about credit hammer the banking sector and investors […]
read more“Reframing The Upside” Of Buying During A Panic
People need to change the way they think about buying assets during a panic, argues the author of today’s article, who notes that “Despite the seemingly obvious upside to buying […]
read moreRisks & Opportunities In The Current Environment Of Fear
“No move is better than a bad move.” This caution regarding how investors respond to the market turmoil brought on by the coronavirus outbreak comes from Jeffrey Sherman, deputy chief […]
read moreWhy Wall Street Is Hailing Uber Again
Uber hasn’t exactly had a smooth ride since its IPO last year, but as today’s article outlines, Wall Street sentiment towards the ride-hailing company has taken a more positive turn […]
read more